Re:Ketamine for the acute treatment of severe suicidal ideation
by phren0logy on Monday March 14, 2022 @06:27PM
(#30679299)
The person assessing the depression response in the psilocybin studies is not in the room with the person while they are under the influence of the substance. The ratings are done on a different day. It's two different people to preserve blinding.
[ Parent
| on HN ]
There are no comments on this comment yet.